MEDIGENE
associated with 0 other trademarks
medicaments for the treatment of [ cardiac, ] cancer [ and metabolic ] diseases in human beings [ and animals ] ; [serums and recombinant proteins as ...

Words that describe this trademark:

human beings  animals  cardiac  cancer  beings  metabolic  treatment  diseases  medicaments  serums 

Serial Number:

75039069

Mark:

MEDIGENE

Status:

Cancelled-Section 8

Status Date:

09-26-2021

Filing Date:

Registration Number:

2240064

Registration Date:

04-20-1999

Goods and Services:

medicaments for the treatment of [ cardiac, ] cancer [ and metabolic ] diseases in human beings [ and animals ] ; [serums and recombinant proteins as vaccines against cancer and infectious diseases; test kits containing antibodies, enzymes, DNA and biochemical solutions for the testing of cardiac diseases, such as congestive heart failure, and cancer diseases, such as cervical and ovarian cancer, melanoma and other epithelial tumors in human beings and animals; diagnostic and therapeutic reagents, such as antibodies, DNA, enzymes and biochemical solutions for clinical medical laboratory use in the field of human and veterinary molecular biology, genetic engineering and bioengineering] laboratory research and development of testing methods in the fields of human [ and veterinary ] molecular biology, genetic engineering and bioengineering, screening for pharmaceutically effective compounds

Mark Description:

N/A

Class:

Scientific and technological services

Type of Mark:

Trademark

Published for Opposition Date:

07-28-1998

Mark Drawing Status:

5S07

Abandon Date:

N/A

Business Name:

WRB-IP LLP

Correspondent Name:

Recent Trademark filings by this company